Literature DB >> 26148801

Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration.

Eleonora M Lad1, Scott W Cousins2, John S Van Arnam3, Alan D Proia2,3.   

Abstract

PURPOSE: Prior research in animal models has suggested that retinal macrophages play an important role in age-related macular degeneration (AMD), but studies have insufficiently characterized the distribution of retinal macrophages in various stages of human AMD.
METHODS: In this case series, we analyzed H&E, periodic acid-Schiff, and CD163 and CD68 immunostained slides from 56 formaldehyde-fixed, paraffin-embedded autopsy eyes of patients over age 75: 11 age-matched, normal eyes, and 45 AMD eyes.
RESULTS: Qualitative analysis of the macula and retinal periphery revealed that all eyes contained a significant number of CD163+ cells but a negligible number of CD68+ cells. In normal eyes and eyes with thin or infrequent basal laminar deposits, CD163+ cells were restricted to the inner retina. In contrast, in AMD eyes with thick basal deposits, choroidal neovascular membranes, and geographic atrophy, qualitatively there was a marked increase in the number and size of the CD163+ cells in the outer retina, sub-retinal, and sub-retinal pigment epithelium space in the macula.
CONCLUSIONS: The changes in number and localization of retinal CD163+ cells in eyes with intermediate-severe AMD support a key role for macrophages in the pathogenesis and progression of the disease. A larger, quantitative study evaluating the distribution of macrophage subpopulations in postmortem AMD eyes is warranted.

Entities:  

Keywords:  Age related-macular degeneration; Histopathology; Inflammation; Macrophages; Postmortem eyes

Mesh:

Substances:

Year:  2015        PMID: 26148801      PMCID: PMC5203931          DOI: 10.1007/s00417-015-3094-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration.

Authors:  Nisha Gupta; Kimberly E Brown; Ann H Milam
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

2.  Photoreceptor synapses degenerate early in experimental choroidal neovascularization.

Authors:  Alejandro Caicedo; Diego G Espinosa-Heidmann; Duco Hamasaki; Yolanda Piña; Scott W Cousins
Journal:  J Comp Neurol       Date:  2005-03-14       Impact factor: 3.215

3.  Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization.

Authors:  Alejandro Caicedo; Diego G Espinosa-Heidmann; Yolanda Piña; Eleut P Hernandez; Scott W Cousins
Journal:  Exp Eye Res       Date:  2005-07       Impact factor: 3.467

4.  Macrophage phenotype as a determinant of biologic scaffold remodeling.

Authors:  Stephen F Badylak; Jolene E Valentin; Anjani K Ravindra; George P McCabe; Ann M Stewart-Akers
Journal:  Tissue Eng Part A       Date:  2008-11       Impact factor: 3.845

5.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

6.  Detection of M2-macrophages in uveal melanoma and relation with survival.

Authors:  Inge H G Bronkhorst; Long V Ly; Ekaterina S Jordanova; Johannes Vrolijk; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-03       Impact factor: 4.799

7.  Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Authors:  P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1995-11

8.  Identification of the haemoglobin scavenger receptor.

Authors:  M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

9.  Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration.

Authors:  S Cherepanoff; P McMenamin; M C Gillies; E Kettle; S H Sarks
Journal:  Br J Ophthalmol       Date:  2009-12-03       Impact factor: 4.638

Review 10.  Macrophages in neovascular age-related macular degeneration: friends or foes?

Authors:  J M Skeie; R F Mullins
Journal:  Eye (Lond)       Date:  2008-07-04       Impact factor: 3.775

View more
  42 in total

1.  DYNAMISM OF DOT SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION DEMONSTRATED WITH ADAPTIVE OPTICS IMAGING.

Authors:  Yuhua Zhang; Xiaolin Wang; Pooja Godara; Tianjiao Zhang; Mark E Clark; C Douglas Witherspoon; Richard F Spaide; Cynthia Owsley; Christine A Curcio
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

2.  Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.

Authors:  Chandrakumar Balaratnasingam; Jeffrey D Messinger; Kenneth R Sloan; Lawrence A Yannuzzi; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2017-01-30       Impact factor: 12.079

Review 3.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

4.  Macrophages or retinal pigment epithelium expressing macrophage markers in age-related macular degeneration? Comment on Lad et al. 2015.

Authors:  Christine A Curcio; Thomas Ach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-20       Impact factor: 3.117

5.  Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.

Authors:  Alessandro Iannaccone; T J Hollingsworth; Diwa Koirala; David D New; Nataliya I Lenchik; Sarka Beranova-Giorgianni; Ivan C Gerling; Marko Z Radic; Francesco Giorgianni
Journal:  Exp Eye Res       Date:  2016-12-15       Impact factor: 3.467

Review 6.  Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms.

Authors:  Michael J Allingham; Priyatham S Mettu; Scott W Cousins
Journal:  Exp Eye Res       Date:  2019-08-31       Impact factor: 3.467

7.  VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; Richard F Spaide; Christine A Curcio
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

Review 8.  A Review of Pathogenic Drivers of Age-Related Macular Degeneration, Beyond Complement, with a Focus on Potential Endpoints for Testing Therapeutic Interventions in Preclinical Studies.

Authors:  Mayur Choudhary; Goldis Malek
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 9.  Microglia versus Monocytes: Distinct Roles in Degenerative Diseases of the Retina.

Authors:  Chen Yu; Christophe Roubeix; Florian Sennlaub; Daniel R Saban
Journal:  Trends Neurosci       Date:  2020-04-17       Impact factor: 13.837

10.  CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma.

Authors:  Milica A Margeta; Eleonora M Lad; Alan D Proia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-02       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.